Then, we measured ING3 levels in benign tissues compared with matched cancer samples and found that elevated ING3 levels correlate with treatment resistance and poor survival, corroborating in vitro assays suggesting that ING3 has oncogenic properties. This evidence concerns the gene ING3 and cancer.